Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 17320513646 |
E-mail: | mike@molcoo.com |
QQ: | 3001071511 |
Skype: | Chat Now! |
Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
Product Name | MF | CAS | Details |
---|
Grb2 SH2 Domain Ligand | C23H36N5O10P | 168423-05-0 | Details |
Acetalin 1, Opioid Receptor Antagonist 1 | C42H61N11O8S2 | 152274-65-2 | Details |
[Tyr34]-pTH (7-34) amide (bovine) | C156H244N48O40S2 | 86292-93-5 | Details |
Substance P (1-7) | C41H65N13O10 | 68060-49-1 | Details |
Secretin Acetate, porcine | C130H220N44O41 | 17034-35-4 | Details |
Somatostatin- 28 (1-14) | C61H105N23O21S | 79243-10-0 | Details |
Substance P (2-11)/Deca-Substance P | C57H86N14O12S | 53749-61-4 | Details |
RGD | C12H22N6O6 | 99896-85-2 | Details |
Substance P (6-11)/Hexa-Substance P | C36H52N8O7S | 51165-07-2 | Details |
Secretin, rat | C129H216N42O42 | 121028-49-7 | Details |
[Tyr27]-pTH (27-48) (human) | C104H159N29O31 | 90686-51-4 | Details |
PAR-3 (1-6) amide (mouse) | C25H36N8O8 | 261521-21-5 | Details |
Secretin, human | C130H220N44O40 | 108153-74-8 | Details |
IL-1 Receptor Peptide (human) | C47H88N14O12S | 141801-03-8 | Details |
Somatostatin-14 (7-14) | C49H66N10O12S | 331627-76-0 | Details |
PAR-3 (1-6) amide (human) | C29H46N10O7 | 1872435-09-0 | Details |
VIP Receptor-Binding Inhibitor L-8-K | C50H77N9O12S | 120550-85-8 | Details |
[Tyr52] PTH (52-84) (human) | C158H262N44O56 | 89492-47-7 | Details |
[Leu8,D-Trp22,Tyr25]-Somatostatin-28 | C138H209N41O40S2 | 77909-99-0 | Details |
[D-Arg1,D-Trp5,7,9,Leu11]-Substance P | C81H110N20O12 | 122481-75-8 | Details |
SH2 Domain Ligand (2) | C66H97N12O24P | 147612-86-0 | Details |
[Sar9] Substance P | C64H100N18O13S | 77128-75-7 | Details |
pTH (3-34) (bovine) | C175H274N52O48S2 | 51257-86-4 | Details |
[D-Trp8]-Somatostatin-14 | C76H104N18O19S2 | 58976-46-8 | Details |
[D-Pro2,D-Phe7,D-Trp9]-Substance P | C72H105N19O13S | 77275-70-8 | Details |
[D-Arg1,D-Trp7,9,Leu11]-Substance P | C75H108N20O13 | 91224-37-2 | Details |
[Tyr1] Somatostatin | C82H108N18O20S2 | 59481-23-1 | Details |
[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P | C67H102N20O13S | 115760-58-2 | Details |
Biotin-Somatostatin-14 | C86H118N20O21S3 | 145251-83-8 | Details |
[Tyr11]-Somatostatin-14 | C76H104N18O20S2 | 59481-27-5 | Details |
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P | C75H108N20O13 | 84676-91-5 | Details |
[D-Phe7]-Somatostatin-14 | C76H104N18O19S2 | 64813-74-7 | Details |
[Nle8’18,Tyr34]-pTH (1-34) amide (bovine) | C185H293N55O50 | 64763-77-5 | Details |
FMRF - related peptide, Pyr - DPFLRFM - NH2 | C44H61N11O10 | 98495-35-3 | Details |
[Nle8’21,Tyr34]-pTH (1-34) amide (rat) | 105267-88-7 | Details |
Substance P (9-11) | C13H26N4O3S | 4652-64-6 | Details |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | C79H109N19O12 | 96736-12-8 | Details |
[Tyr8] Substance P | C63H98N18O14S | 55614-10-3 | Details |
Substance P (1-9) | C52H77N15O12 | 57468-17-4 | Details |
Somatostatin-28 | C137H207N41O39S3 | 75037-27-3 | Details |
Tyr-Somatostatin-28 | C146H216N42O41S3 | 86649-84-5 | Details |
PAR-2(1-6) (human) | C28H53N7O8 | 202933-49-1 | Details |
pTH-Related Protein Splice Isoform 3 (140-173) (human) | 139872-85-8 | Details |
[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11) | C58H77N13O10 | 89430-34-2 | Details |
SH2 Domain Ligand (5) | C41H62N7O16PS | 201422-05-1 | Details |
[Asn10,Leu11,D-Trp12]-pTH-Related Protein (7-34) amide (human, rat) | C162H254N50O36 | 129622-68-0 | Details |
RGD-4C | C42H60N14O16S4 | 332179-76-7 | Details |
Sarafotoxin S6b | C110H159N27O34S5 | 120972-53-4 | Details |
Substance P-methyl ester | C64H99N17O14S | 76260-78-1 | Details |
Ac-Choline Receptor α1(129-145) | C90H136N22O28S2 | 194737-11-6 | Details |
Epidermal Growth Factor Receptor Peptide (985-996) | C61H93N13O23 | 96249-43-3 | Details |
[Pyr5]-Substance P (5-11) | C41H57N9O9S | 56104-22-4 | Details |
Y-R-G-D-S | C24H36N8O10 | 134282-68-1 | Details |
[Pyr6,Pro9]-Substance P (6-11) | C39H53N7O7S | 79775-19-2 | Details |
R-G-D-C | C15H27N7O7S | 109292-46-8 | Details |
R-G-D-S-P-A-S-S-K-P | C40H68N14O16 | 91575-25-6 | Details |
[D-Pro4,D-Trp7,9,10]-Substance P (4-11) | C62H74N14O10S | 86917-57-9 | Details |
Substance P | C63H98N18O13S | 12769-48-1 | Details |
Biotin-Substance P | C73H112N20O15S2 | 87468-58-4 | Details |
[D-Trp12,Tyr34]-pTH (7-34) amide (bovine) | 118102-98-0 | Details |
[Pro9] Substance P | C66H102N18O13S | 104486-69-3 | Details |
[D-Pro2, D-Trp7,9]-Substance P | C74H106N20O13S | 80434-86-2 | Details |
PAR-4 (1-6) (human) | C28H41N7O9 | 225779-44-2 | Details |
Substance P, Free Acid | C63H97N17O14S | 71977-09-8 | Details |
Substance P (5-11)/Hepta-Substance P | C41H60N10O9S | 51165-09-4 | Details |
PAR-4 (1-6) amide (mouse) | C33H46N8O7 | 245443-52-1 | Details |
[D-Glu5,D-Trp7,9,10]-Substance P (5-11) | C57H66N12O10S | 289632-61-7 | Details |
Ac-Neurotrophin Receptor (368-381) amide (human) | C69H124N22O19 | 197230-90-3 | Details |
[Asn76] PTH (64-84), human | C94H163N27O35 | 129449-07-6 | Details |
Somatostatin- 25 | C127H191N37O34S3 | 76461-17-1 | Details |
[Lys4] Sarafotoxin S6c | C103H151N27O37S5 | 116495-45-5 | Details |
[D-Trp2,7,9]-Substance P | C80H109N21O13S | 100930-11-8 | Details |
Protease Activated Receptor - 2, PAR - 2 Agonist, amide | C28H54N8O7 | 190383-13-2 | Details |
[Tyr43] PTH (43-68) (human) | C126H208N42O43 | 92952-95-9 | Details |
[Nle11] Substance P | C64H100N18O13 | 57462-42-7 | Details |
G-R-G-D-T-P | C23H39N9O10 | 108682-58-2 | Details |
FMRF amide | C29H42N8O4S | 152165-14-5 | Details |
SH2 Domain Ligand (1) | C36H56N7O13PS | 157382-69-9 | Details |
KGF Receptor Peptide | C114H174N30O42S | 161338-76-7 | Details |
Somatostatin-14 (3-10) | C52H72N12O11S | 331627-82-8 | Details |
[Phe1,Ser2,Tyr6]-PAR-1 (1-6) amide (human) | C39H60N10O8 | 245329-02-6 | Details |
Acetalin 3, Opioid Receptor Antagonist 3 | C44H66N12O7S2 | 152274-67-4 | Details |
[Tyr1] -pTH (1-34), human | 213779-10-3 | Details |
PAR-3 (1-6) (human) | C29H45N9O8 | 320347-28-2 | Details |
[Pyr6]-Substance P (6-11) | C36H49N7O7S | 61123-13-5 | Details |
pTH (13-34) (human) | C125H199N39O33S | 81306-64-1 | Details |
Substance P (7-11) | C31H44N6O5S | 51165-05-0 | Details |
Sarafotoxin S6a | C105H156N28O34S5 | 126738-34-9 | Details |
Tyr-Somatostatin-14 | C85H113N19O21S2 | 58100-03-1 | Details |
[Tyr6,D-Phe7,D-His9]-Substance P (6-11) | C44H57N9O7S | 145194-26-9 | Details |
Substance P (4-11)/Octa-Substance P | C46H67N11O10S | 53749-60-3 | Details |
[Nle8’18,Tyr34]-pTH (3-34) amide (bovine) | C177H279N53O48 | 64297-16-1 | Details |
NTB (Naltriben) | C50H67N11O11S2 | 103429-31-8 | Details |
Secretin (5 - 27), porcine | C115H200N38O34 | 19665-15-7 | Details |
pTH (28-48) (human) | C95H150N28O29 | 83286-22-0 | Details |
Salusin-α | C114H192N40O30 | 624735-22-4 | Details |
RGDV | C17H31N7O7 | 93674-99-8 | Details |
Opioid receptor antagonist | C44H66N14O7S2 | 152274-66-3 | Details |
Substance P (1-4) | C22H40N8O5 | 57468-16-3 | Details |
Sarafotoxin S6c | C103H147N27O37S5 | 121695-87-2 | Details |
Product Total: Product Page: | ||||
69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 |